Thus, our results uncovered that BET inhibitor JQ1 ameliorates PCN-mediated PA lung infection by fine-tuning macrophage activities via maintaining oxidative free radical homeostasis in vitro and in vivo, indicating a potential innate immune-supporting strategy against PA-related infection. Here, DNER is linked to infection.